Sekwon Jang, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    Sun Biopharma
    Date added: 
    04/07/2023
    Mitigation strategy: 
    Attest
    Relationship end date: 
    07/15/2022
    Date reviewed: 
    03/09/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    Replimune
    Date added: 
    07/24/2023
    Mitigation strategy: 
    Attest
    Relationship end date: 
    06/02/2023
    Date reviewed: 
    03/09/2024
Return to 2024 Inova Melanoma and Cutaneous Oncology Conference 03/27/2024